Compare Quest Diagnostics Inc (DGX) vs EOG Resources Inc (EOG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs EOG Resources Inc — how do they compare? Quest Diagnostics Inc trades at $230.72 (market cap $25.06B), while EOG Resources Inc trades at $148.4 (market cap $75.64B). The key difference: EOG Resources Inc is far larger — about 3× Quest Diagnostics Inc's market cap, and EOG Resources Inc pays the higher dividend (2.83%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and EOG Resources Inc for 59 Days on average.
| DGX | EOG | |
|---|---|---|
Market Cap | $25.06B | $75.64B |
Volume | 927,361 | 2,041,336 |
Sector | Health | Energy |
52-Week High | $247.45 | $153.74 |
52-Week Low | $173.49 | $101.78 |
Typical Hold Time | 56 Days | 59 Days |
Enterprise Value | $30.82B | $78.99B |
Dividend Yield | 1.52% | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.03% with consistent earnings beats in recent quarters. The stock shows bearish technical signals despite strong fundamentals including 9.19% net margins and 14.35% ROE. Recent developments include a partnership with Apple Health app and concerns about Medicare reimbursement cuts affecting future revenue streams.
The outlook remains cautiously optimistic with a $250 consensus price target representing 8.3% upside potential. Key opportunities include growth in advanced diagnostics and consumer testing demand, while risks center on Medicare payment reductions and competitive pressures in the diagnostic services market.
EOG Resources trades at $148.51, up 2.93% today, with a bullish technical signal from moving averages and strong fundamental metrics including a P/E of 11.22 and net income margin of 25.81%. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $5.07 exceeding expectations. Recent news highlights robust operational execution and disciplined capital allocation, with a CFO transition announced in September 2026.
Outlook remains positive with a consensus price target of $164.77, offering ~11% upside. Key opportunities include 5% oil volume growth guidance and strong free cash flow generation. Risks involve oil price volatility, as seen in recent price retreats, and execution of leadership transition. The stock presents a compelling value with no sell ratings among 66 analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →
